The objective of this proposal is to develop a novel cell-free system that would facilitate rapid selection of functional fragments of monoclonal antibodies. The system descibed is based on well-established molecular mechanisms. For antibody selection, a cDNA library encoding the single-chain variable region fragment (scFv) can be used in an in vitro system to generate a large pool of scFv's that can be selected with target antigens. The cDNA for the desired scFv can be recovered and used to express large quantities of recombinant scFv. This procedure is more efficient, less expensive and technically easier than all existing methods for antibody selection. It also has the potential to be adapted to high throughput screening systems, or modified to screen binding proteins other than antibodies.

Proposed Commercial Applications

The goal for the phase I studies is to test the feasibility of this innovative technology. Once developed, it may have a major impact on proteomics, cancer diagnosis and drug development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA089990-01
Application #
6294474
Study Section
Special Emphasis Panel (ZRG1-SSS-4 (01))
Program Officer
Duglas-Tabor, Yvonne
Project Start
2001-03-15
Project End
2002-02-28
Budget Start
2001-03-15
Budget End
2002-02-28
Support Year
1
Fiscal Year
2001
Total Cost
$99,700
Indirect Cost
Name
Allele Biotechnology and Pharmaceuticals
Department
Type
DUNS #
021345447
City
San Diego
State
CA
Country
United States
Zip Code
92121